Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Christopher Cultrara"'
Autor:
Lorenzo Galluzzi, Jenny Zilberberg, Amelia Zellander, Kenneth Kirby, Christopher Uhl, Christopher Cultrara, Essam Abed Elrazaq, David W Andrews, Charles B Scott, Mark A Exley
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 8 (2023)
Background IGV-001 is a personalized, autologous cancer cell-based immunotherapy conceived to deliver a tumor-derived antigenic payload in the context of immunostimulatory signals to patients with glioblastoma (GBM). IGV-001 consists of patient-deriv
Externí odkaz:
https://doaj.org/article/4dcff276a1bf4922837be3e5877e9195
Autor:
David Andrews, Mark Exley, Charles Scott, Jenny Zilberberg, Amelia Zellander, Kenneth Kirby, Christopher Uhl, Christopher Cultrara
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/20e397c8f37e4e6e9cd181847ee0c01d
Autor:
Christopher Cultrara, Kenneth Kirby, Essam Elrazaq, Christopher Uhl, Amelia Zellander, Lorenzo Galluzzi, Mark Exley, Jenny Zilberberg
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Amelia Zellander, Christopher Uhl, Christopher Cultrara, Kenneth Kirby, Essam Elrazaq, Charles Scott, David Andrews, Jenny Zilberberg, Mark Exley
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Christopher Cultrara, Kenneth Kirby, Essam Elrazaq, Christopher Uhl, Amelia Zellander, Lorenzo Galluzzi, Mark Exley, Jenny Zilberberg
Publikováno v:
Cancer Research. 83:1812-1812
Background: Imvax is developing a novel personalized immunotherapy platform that combines whole-tumor derived cells with an antisense oligonucleotide against insulin-like growth factor 1-receptor in implantable biodiffusion chambers (BDCs; 0.1 μm po
Autor:
Jenny Zilberberg, Amelia Zellander, Christopher Uhl, Christopher Cultrara, Kenneth kirby, Essam Elazaq, Charles B. Scott, David W. Andrews, Mark Exley
Publikováno v:
Cancer Research. 82:626-626
Background: IGV-001 is a novel immunotherapy that combines irradiated patient-derived glioblastoma tumor cells and an antisense oligonucleotide against insulin-like growth factor type 1 receptor (IMV-001) in biodiffusion chambers (BDC). We recently r
Publikováno v:
Cancer Research. 79:5171-5171
Background: Glucose regulated protein 78 (GRP78) is a resident chaperone of the endoplasmic reticulum and a master regulator of the unfolded protein response under physiological and pathological cell stress conditions. GRP78 is overexpressed in many